Strategic Partnerships VIVUS LLC shows active collaboration activity with telehealth platforms and international clinics, indicating a willingness to form partnerships to expand patient access and distribution channels. Target potential: telemedicine networks, contract sales organizations, and regional distributors to accelerate reach of their obesity and metabolic therapies.

Global Expansion Recent international clinic launches and partnerships ( Kuwait clinic, Korea market expansion) suggest readiness to scale products internationally. Business development can explore co-marketing, local regulatory advisory, and regional manufacturing or supply agreements to support global commercialization of their portfolio.

Therapeutic Focus Portfolio emphasis on obesity and related metabolic disorders, including Qsymia and adolescent safety data, indicates channels with endocrinology, primary care, pediatrics, and weight management services. Opportunities exist for payer-focused access programs and clinical education partnerships to drive adoption.

Clinical Capability Strong emphasis on clinical development and safety/efficacy profile positions VIVUS as a partner for phase-related collaborations, post-marketing surveillance, and real-world evidence generation. Potential to pursue co-development or sponsored research agreements with academic centers and CROs.

Digital & Tech Readiness Adoption of cloud and collaboration tools (AWS, Azure, iCIMS, Microsoft 365, Teams) and a telehealth engagement initiative signals readiness for digital health partnerships, e-sourcing, and scalable patient engagement solutions. Sell complementary digital health services, data analytics, and integrated telemedicine offerings.